# ARS Pharmaceuticals, Inc.: filings

SPRY · Nasdaq · CIK 1671858 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/spry.md) · [Financials](/companies/spry/financials.md) · [Filings](/companies/spry/filings.md) · [Insiders](/companies/spry/insiders.md)

## Reports and events: 120 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 230, 144 67, 8-K 66, 3 34, 10-Q 17, DEFA14A 11, SC 13G/A 10, CORRESP 9, SC 13D 9, UPLOAD 8, D 7, S-8 7, SC 13G 7, 10-K 6, DEF 14A 6, SC 13D/A 6, SCHEDULE 13D/A 5, ARS 4, EFFECT 3, SCHEDULE 13G/A 3, 144/A 2, 3/A 2, 4/A 2, S-1/A 2, S-3 2, SCHEDULE 13G 2, SEC STAFF LETTER 2, 10-Q/A 1, 424B4 1, 8-A12B 1, 8-K/A 1, CERT 1, D/A 1, DEFM14A 1, DRS 1, PREM14A 1, PRER14A 1, S-1 1, S-1MEF 1, S-3ASR 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-13 | 16:05 ET | [10-Q](/filings/0001193125-26-349140.md) | Quarterly report, period 2026-06-30 | 0001193125-26-349140 |
| 2026-08-13 | 16:03 ET | [8-K](/filings/0001193125-26-349127.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-349127 |
| 2026-07-17 | 16:02 ET | [8-K](/filings/0001193125-26-307773.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-307773 |
| 2026-07-07 | 16:38 ET | [8-K](/filings/0001193125-26-297554.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-297554 |
| 2026-06-25 | 17:01 ET | [8-K](/filings/0001193125-26-282994.md) | 5.07 Shareholder vote results | 0001193125-26-282994 |
| 2026-05-15 | 06:17 ET | [10-Q](/filings/0001193125-26-225142.md) | Quarterly report, period 2026-03-31 | 0001193125-26-225142 |
| 2026-05-15 | 06:02 ET | [8-K](/filings/0001193125-26-225055.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-225055 |
| 2026-05-13 | 08:15 ET | [8-K](/filings/0001193125-26-220671.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-220671 |
| 2026-04-29 | 16:00 ET | [DEF 14A](/filings/0001193125-26-191433.md) | Proxy statement, period 2026-06-24 | 0001193125-26-191433 |
| 2026-03-09 | 06:07 ET | [10-K](/filings/0001193125-26-097478.md) | Annual report, period 2025-12-31 | 0001193125-26-097478 |
| 2026-03-09 | 06:01 ET | [8-K](/filings/0001193125-26-097467.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-097467 |
| 2025-11-10 | 06:04 ET | [10-Q](/filings/0001193125-25-273111.md) | Quarterly report, period 2025-09-30 | 0001193125-25-273111 |
| 2025-11-10 | 06:02 ET | [8-K](/filings/0001193125-25-273107.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-273107 |
| 2025-10-01 | 21:19 ET | [SCHEDULE 13D/A](/filings/0001346824-25-000011.md) | Ownership report, active investor, amended | 0001346824-25-000011 |
| 2025-09-29 | 16:15 ET | [8-K](/filings/0001193125-25-223228.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-223228 |
| 2025-08-28 | 21:45 ET | [8-K](/filings/0001193125-25-190202.md) | 8.01 Other events | 0001193125-25-190202 |
| 2025-08-13 | 07:03 ET | [10-Q](/filings/0000950170-25-107618.md) | Quarterly report, period 2025-06-30 | 0000950170-25-107618 |
| 2025-08-13 | 07:02 ET | [8-K](/filings/0000950170-25-107617.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-107617 |
| 2025-08-01 | 18:06 ET | [SCHEDULE 13D/A](/filings/0001193805-25-001146.md) | Ownership report, active investor, amended | 0001193805-25-001146 |
| 2025-07-22 | 19:38 ET | [SCHEDULE 13D/A](/filings/0001193805-25-001080.md) | Ownership report, active investor, amended | 0001193805-25-001080 |
| 2025-07-02 | 08:24 ET | [SCHEDULE 13D/A](/filings/0001193805-25-000963.md) | Ownership report, active investor, amended | 0001193805-25-000963 |
| 2025-06-26 | 16:15 ET | [8-K](/filings/0001193125-25-148922.md) | 5.07 Shareholder vote results | 0001193125-25-148922 |
| 2025-05-14 | 07:03 ET | [10-Q](/filings/0000950170-25-070900.md) | Quarterly report, period 2025-03-31 | 0000950170-25-070900 |
| 2025-05-14 | 07:01 ET | [8-K](/filings/0000950170-25-070899.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-070899 |
| 2025-05-02 | 08:05 ET | [8-K](/filings/0001193125-25-110696.md) | 1.01 Entry into a material agreement | 0001193125-25-110696 |
| 2025-04-29 | 16:01 ET | [DEF 14A](/filings/0000950170-25-060075.md) | Proxy statement, period 2025-06-25 | 0000950170-25-060075 |
| 2025-03-24 | 19:57 ET | [SCHEDULE 13D/A](/filings/0001193805-25-000363.md) | Ownership report, active investor, amended | 0001193805-25-000363 |
| 2025-03-20 | 07:04 ET | [10-K](/filings/0000950170-25-042320.md) | Annual report, period 2024-12-31 | 0000950170-25-042320 |
| 2025-03-20 | 07:02 ET | [8-K](/filings/0000950170-25-042317.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-042317 |
| 2025-03-05 | 17:18 ET | [8-K](/filings/0001193125-25-047351.md) | 8.01 Other events | 0001193125-25-047351 |
| 2025-01-13 | 08:08 ET | [8-K](/filings/0001193125-25-005014.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-005014 |
| 2024-12-06 | 16:05 ET | [10-Q/A](/filings/0001193125-24-272445.md) | Quarterly report, amended, period 2024-09-30 | 0001193125-24-272445 |
| 2024-11-13 | 07:02 ET | [10-Q](/filings/0000950170-24-125924.md) | Quarterly report, period 2024-09-30 | 0000950170-24-125924 |
| 2024-11-13 | 07:00 ET | [8-K](/filings/0000950170-24-125921.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-125921 |
| 2024-11-12 | 08:01 ET | [8-K](/filings/0001193125-24-255185.md) | 1.01 Entry into a material agreement | 0001193125-24-255185 |
| 2024-10-15 | 07:02 ET | [8-K](/filings/0001193125-24-237191.md) | 1.01 Entry into a material agreement | 0001193125-24-237191 |
| 2024-09-23 | 16:15 ET | [8-K](/filings/0001193125-24-223676.md) | 1.01 Entry into a material agreement | 0001193125-24-223676 |
| 2024-08-12 | 07:59 ET | [8-K](/filings/0001193125-24-198384.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-198384 |
| 2024-08-06 | 16:05 ET | [10-Q](/filings/0000950170-24-091776.md) | Quarterly report, period 2024-06-30 | 0000950170-24-091776 |
| 2024-08-06 | 16:04 ET | [8-K](/filings/0000950170-24-091745.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-091745 |
| 2024-06-28 | 15:15 ET | [8-K](/filings/0001193125-24-172166.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-172166 |
| 2024-06-28 | 06:46 ET | [8-K](/filings/0001193125-24-171204.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-171204 |
| 2024-06-21 | 17:00 ET | [8-K](/filings/0001193125-24-165812.md) | 5.07 Shareholder vote results | 0001193125-24-165812 |
| 2024-06-17 | 20:47 ET | [SC 13D/A](/filings/0001193125-24-162824.md) | Ownership report, active investor, amended | 0001193125-24-162824 |
| 2024-06-11 | 19:18 ET | [SC 13D/A](/filings/0001193125-24-159314.md) | Ownership report, active investor, amended | 0001193125-24-159314 |
| 2024-05-10 | 07:01 ET | [8-K](/filings/0001193125-24-135721.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-135721 |
| 2024-05-09 | 16:12 ET | [10-Q](/filings/0000950170-24-056967.md) | Quarterly report, period 2024-03-31 | 0000950170-24-056967 |
| 2024-05-09 | 16:08 ET | [8-K](/filings/0000950170-24-056934.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-056934 |
| 2024-04-26 | 16:02 ET | [DEF 14A](/filings/0000950170-24-049071.md) | Proxy statement, period 2024-06-20 | 0000950170-24-049071 |
| 2024-03-29 | 16:14 ET | [SC 13D/A](/filings/0001104659-24-041150.md) | Ownership report, active investor, amended | 0001104659-24-041150 |

Page 1 of 3. [Older](/companies/spry/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:39 ET. No prices; not investment advice.